MoonLake Immunotherapeutics (MLTX) Stock Price & Financial Analysis
MoonLake Immunotherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About MoonLake Immunotherapeutics
What is the current stock price for MLTX?
As of the latest trading session, MLTX stock trades at $17.36. The 52-week range is $5.95–$62.75, with a day range of $16.02–$17.53.
What is the P/E ratio for MLTX?
The P/E ratio (Price-to-Earnings) for MLTX is shown in the Key Statistics section. This valuation metric helps compare MoonLake Immunotherapeutics to industry peers.
Does MLTX pay dividends?
MoonLake Immunotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MLTX?
Based on 9 analysts, the consensus for MLTX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of MLTX?
MoonLake Immunotherapeutics's market capitalization is $1.12B, classifying it as a small-cap company. MoonLake Immunotherapeutics operates in the Healthcare sector within the Biotechnology industry.